Monday, October 28, 2013

Oncogenesis - Table of Contents alert Volume 2, October 2013

Oncogenesis

Advertisement
DNA methylation - now there's a way to study it.
Diagenode provides a full suite of products dedicated to epigenetics research. Our innovative DNA methylation product line includes:
  • Trusted and validated antibodies - plus the provider of the original 5-mc 33D3 antibody
  • Reliable and robust kits for magnetic MeDIP and hMeDIP, bisulfite conversion, and more
  • Industry's BEST methyl binding domain (MBD) kit as cited in PLOS ONE
Learn more.

TABLE OF CONTENTS

Volume 2, October 2013

In this issue
Original Articles
Advertisement
 

Molecular and chemical targets for tumor-selective cancer treatment
Topic Editors: Yoshihiro Suzuki-Karasaki, Harun M. Said, and Evzen Krepela ¦ Submission deadline: 31 Mar 2014

This Research Topic from Frontiers in Oncology aims to integrate our current understanding regarding this important field of cancer research in an attempt to establish the effectiveness of mitochondrial ROS-generating substances in tumor-selective apoptosis. 

Contribute this this Research Topic or even host your own. 
Sign up for e-alerts Sign up for e-alerts
Web feed
Advertisement
Nature Collections
TCGA pan-cancer analysis


The Cancer Genome Atlas Pan-cancer initiative examines the similarities and differences among the genomic and cellular alterations found in the first dozen tumor types to be profiled by TCGA. This first look across cancer offers new tools in genomics and bioinformatics and the prospect of repurposing targeted therapies directed by the molecular pathology of the tumors in addition to their clinical classification.

View the Collection and accompanying Podcast, FREE at:
www.nature.com/tcga

Produced with support from 
Illumina 

Original Articles

Top

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin

J Cai, C Yang, Q Yang, H Ding, J Jia, J Guo, J Wang and Z Wang

Oncogenesis 2013 2: e75; 10.1038/oncsis.2013.39

Abstract | Full Text

The histone variant MacroH2A regulates Ca2+ influx through TRPC3 and TRPC6 channels

J-M Kim, K Heo, J Choi, K Kim and W An

Oncogenesis 2013 2: e77; 10.1038/oncsis.2013.40

Abstract | Full Text

Knockdown of RON receptor kinase delays but does not prevent tumor progression while enhancing HGF/MET signaling in pancreatic cancer cell lines

S Zhao, L Cao and J W Freeman

Oncogenesis 2013 2: e76; 10.1038/oncsis.2013.36

Abstract | Full Text

Advertisement
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: